# The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient

> **NCT00000661** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 8 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Oxazepam
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00000661
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 8 (—)
- **Last updated:** 2008-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000661, "The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*